Clinical Trials Browser

Active not recruiting × Triple Negative Breast Neoplasms × gedatolisib × Clear all

NCT03911973 2024-06-07

Gedatolisib Plus Talazoparib in Advanced Triple Negative or BRCA1/2 Positive, HER2 Negative Breast Cancers

Phase 1/2 Active not recruiting

Triple Negative Breast Neoplasms